Vaccinology in the era of high-throughput biology

Vaccination has been tremendously successful saving lives and preventing infections. However, the development of vaccines against global pandemics such as HIV, malaria and tuberculosis has been obstructed by several challenges. A major challenge is the lack of knowledge about the correlates and mechanisms of protective immunity. Recent advances in the application of systems biological approaches to analyse immune responses to vaccination in humans are beginning to yield new insights about mechanisms of vaccine immunity, and to define molecular signatures, induced rapidly after vaccination, that correlate with and predict vaccine induced immunity. Here, we review these advances and discuss the potential of this systems vaccinology approach in defining novel correlates of protection in clinical trials, and in infection-induced ‘experimental challenge models' in humans.

[1]  Bastian R. Angermann,et al.  Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses , 2008, The Journal of experimental medicine.

[2]  T. Vesikari,et al.  Oil-in-water emulsion adjuvant with influenza vaccine in young children. , 2011, The New England journal of medicine.

[3]  S. McWeeney,et al.  Systems immunogenetics of vaccines. , 2013, Seminars in immunology.

[4]  B. Pulendran.  The varieties of immunological experience: of pathogens, stress, and dendritic cells. , 2015, Annual review of immunology.

[5]  Charles N. Serhan,et al.  Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators , 2008, Nature Reviews Immunology.

[6]  J. Yewdell,et al.  MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines , 2011, Science Translational Medicine.

[7]  Shuzhao Li,et al.  Systems vaccinology: learning to compute the behavior of vaccine induced immunity , 2012, Wiley interdisciplinary reviews. Systems biology and medicine.

[8]  Caroline H. Johnson,et al.  Challenges and opportunities of metabolomics , 2012, Journal of cellular physiology.

[9]  U. Grohmann,et al.  Modulation of tryptophan catabolism by regulatory T cells , 2003, Nature Immunology.

[10]  Russell G. Jones,et al.  Enhancing CD 8 T Cell Memory by Modulating Fatty Acid Metabolism , 2010 .

[11]  Arthur Liberzon,et al.  A description of the Molecular Signatures Database (MSigDB) Web site. , 2014, Methods in molecular biology.

[12]  C. Marwick.  Volunteers in typhoid infection study will aid future vaccine development. , 1998, JAMA.

[13]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Kiyoko F. Aoki-Kinoshita,et al.  From genomics to chemical genomics: new developments in KEGG , 2005, Nucleic Acids Res..

[15]  Helder I Nakaya,et al.  TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination. , 2014, Immunity.

[16]  David A. Sack,et al.  Validation of a Volunteer Model of Cholera with Frozen Bacteria as the Challenge , 1998, Infection and Immunity.

[17]  B. Pulendran,et al.  Systems vaccinology: its promise and challenge for HIV vaccine development. , 2012, Current opinion in HIV and AIDS.

[18]  B. Pulendran.  Systems vaccinology: Probing humanity’s diverse immune systems with vaccines , 2014, Proceedings of the National Academy of Sciences.

[19]  Sandra Romero-Steiner,et al.  Molecular signatures of antibody responses derived from a systems biological study of 5 human vaccines , 2013, Nature Immunology.

[20]  Zhining Wang,et al.  Expression of genes associated with immunoproteasome processing of major histocompatibility complex peptides is indicative of protection with adjuvanted RTS,S malaria vaccine. , 2010, The Journal of infectious diseases.

[21]  S. Shen-Orr,et al.  Computational deconvolution: extracting cell type-specific information from heterogeneous samples. , 2013, Current opinion in immunology.

[22]  Virginia Pascual,et al.  Host Immune Transcriptional Profiles Reflect the Variability in Clinical Disease Manifestations in Patients with Staphylococcus aureus Infections , 2012, PloS one.

[23]  Robert Langer,et al.  CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling , 2014, Cell.

[24]  D. Bernstein,et al.  Serological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial. , 2014, JAMA.

[25]  Bali Pulendran,et al.  Immunological mechanisms of vaccination , 2011, Nature Immunology.

[26]  Shuzhao Li,et al.  Systems biological approaches to measure and understand vaccine immunity in humans. , 2013, Seminars in immunology.

[27]  Sandra Romero-Steiner,et al.  Molecular signatures of antibody responses derived from a systems biology study of five human vaccines , 2022 .

[28]  T. Anthony,et al.  Uncharged tRNA and Sensing of Amino Acid Deficiency in Mammalian Piriform Cortex , 2005, Science.

[29]  Eva K. Lee,et al.  Systems Analysis of Immunity to Influenza Vaccination across Multiple Years and in Diverse Populations Reveals Shared Molecular Signatures. , 2015, Immunity.

[30]  Matthew R. Laird,et al.  InnateDB: facilitating systems-level analyses of the mammalian innate immune response , 2008, Molecular systems biology.

[31]  P. Romano,et al.  The Interferon-induced Double-stranded RNA-activated Protein Kinase PKR Will Phosphorylate Serine, Threonine, or Tyrosine at Residue 51 in Eukaryotic Initiation Factor 2α* , 1999, The Journal of Biological Chemistry.

[32]  B. Pulendran,et al.  Systems biology of vaccination in the elderly. , 2013, Current topics in microbiology and immunology.

[33]  T. Ideker,et al.  A new approach to decoding life: systems biology. , 2001, Annual review of genomics and human genetics.

[34]  Jeffrey A. Wiser,et al.  ImmPort: disseminating data to the public for the future of immunology , 2014, Immunologic Research.

[35]  J. Farrar,et al.  An Outpatient, Ambulant-Design, Controlled Human Infection Model Using Escalating Doses of Salmonella Typhi Challenge Delivered in Sodium Bicarbonate Solution , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[36]  Russell G. Jones,et al.  Enhancing CD8 T-cell memory by modulating fatty acid metabolism , 2009, Nature.

[37]  Jingtai Han.  Understanding biological functions through molecular networks , 2008, Cell Research.

[38]  Kelly Domico,et al.  Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines. , 2013, Immunity.

[39]  B. Haribabu,et al.  Regulation of dendritic cell migration and adaptive immune response by leukotriene B4 receptors: a role for LTB4 in up-regulation of CCR7 expression and function. , 2007, Blood.

[40]  Bali Pulendran,et al.  Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity , 2006, The Journal of experimental medicine.

[41]  Virginia Pascual,et al.  An Interferon-Inducible Neutrophil-Driven Blood Transcriptional Signature in Human Tuberculosis , 2010, Nature.

[42]  Helga Thorvaldsdóttir,et al.  Molecular signatures database (MSigDB) 3.0 , 2011, Bioinform..

[43]  Mark P. Styczynski,et al.  Comparative transcriptomics and metabolomics in a rhesus macaque drug administration study , 2014, Front. Cell Dev. Biol..

[44]  Rona S. Gertner,et al.  Single cell RNA Seq reveals dynamic paracrine control of cellular variation , 2014, Nature.

[45]  Rawi Ramautar,et al.  Human metabolomics: strategies to understand biology. , 2013, Current opinion in chemical biology.

[46]  Cécile Viboud,et al.  Antibody response to influenza vaccination in the elderly: a quantitative review. , 2006, Vaccine.

[47]  Kenneth H. Buetow,et al.  PID: the Pathway Interaction Database , 2008, Nucleic Acids Res..

[48]  Virginia Pascual,et al.  A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. , 2008, Immunity.

[49]  R. Webby,et al.  Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study , 2013, The Lancet. Infectious diseases.

[50]  Eva K. Lee.  Large-Scale Optimization-Based Classification Models in Medicine and Biology , 2007, Annals of Biomedical Engineering.

[51]  A. Barrett,et al.  Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place? , 2009, Current opinion in immunology.

[52]  M. Peters,et al.  Systematic identification of trans eQTLs as putative drivers of known disease associations , 2013, Nature Genetics.

[53]  Mark M. Davis,et al.  Apoptosis and other immune biomarkers predict influenza vaccine responsiveness , 2014, Molecular Systems Biology.

[54]  O. Ramilo,et al.  Plasticity and Virus Specificity of the Airway Epithelial Cell Immune Response during Respiratory Virus Infection , 2012, Journal of Virology.

[55]  A. Barabasi,et al.  Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.

[56]  H. L. Hartley,et al.  Manuscript Preparation , 2022 .

[57]  V. Pascual,et al.  Differences in antibody responses between trivalent inactivated influenza vaccine and live attenuated influenza vaccine correlate with the kinetics and magnitude of interferon signaling in children. , 2014, The Journal of infectious diseases.

[58]  Sumit K Chanda,et al.  Identifying HIV-1 host cell factors by genome-scale RNAi screening. , 2011, Methods.

[59]  Max Theiler,et al.  THE USE OF YELLOW FEVER VIRUS MODIFIED BY IN VITRO CULTIVATION FOR HUMAN IMMUNIZATION , 1937, The Journal of experimental medicine.

[60]  B. Rovner,et al.  Randomized clinical trial: a pilot study investigating the safety and effectiveness of an escalating dose of peginterferon &agr;-2a monotherapy for 48 weeks compared with standard clinical care in patients with hepatitis C cirrhosis , 2012, European journal of gastroenterology & hepatology.

[61]  D. Zak,et al.  Systems biology of innate immunity , 2009, Immunological reviews.

[62]  Molly S Bray,et al.  Integrative genomic analysis of the human immune response to influenza vaccination , 2013, eLife.

[63]  B. Murphy,et al.  Evaluation of the infectivity, immunogenicity, and efficacy of live cold-adapted influenza B/Ann Arbor/1/86 reassortant virus vaccine in adult volunteers. , 1990, The Journal of infectious diseases.

[64]  Gary D Bader,et al.  A draft map of the human proteome , 2014, Nature.

[65]  Léon Personnaz,et al.  Enrichment or depletion of a GO category within a class of genes: which test? , 2007, Bioinform..

[66]  R. Sauerwein,et al.  Experimental human challenge infections can accelerate clinical malaria vaccine development , 2010, Nature Reviews Immunology.

[67]  Shuzhao Li,et al.  Systems vaccinology: Probing humanity’s diverse immune systems with vaccines , 2014, Proceedings of the National Academy of Sciences.

[68]  Shuzhao Li,et al.  Vaccine Activation of the Nutrient Sensor GCN2 in Dendritic Cells Enhances Antigen Presentation , 2014, Science.

[69]  Pablo Tamayo,et al.  Gene signatures related to B‐cell proliferation predict influenza vaccine‐induced antibody response , 2014, European journal of immunology.

[70]  Patrick C. Wilson,et al.  Rapid cloning of high-affinity human monoclonal antibodies against influenza virus , 2008, Nature.

[71]  C. Ockenhouse,et al.  Controlled human malaria infection. , 2014, The Journal of infectious diseases.

[72]  Eva K. Lee,et al.  Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans , 2009, Nature Immunology.

[73]  Yuri Kotliarov,et al.  Global Analyses of Human Immune Variation Reveal Baseline Predictors of Postvaccination Responses , 2014, Cell.

[74]  J. Buhmann,et al.  Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry , 2014, Nature Methods.

[75]  E. Schadt,et al.  Unifying immunology with informatics and multiscale biology , 2014, Nature Immunology.

[76]  Eva K. Lee,et al.  Systems Biology of Seasonal Influenza Vaccination in Humans , 2011, Nature Immunology.

[77]  S. Akira,et al.  The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5 , 2001, Nature.

[78]  V. Bronte,et al.  Regulation of immune responses by L-arginine metabolism , 2005, Nature Reviews Immunology.